Clonal resistance analyses of HIV type-1 after failure of therapy with didanosine, lamivudine and tenofovir
about
Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitroThe evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains.Antiretroviral treatment interruption and loss to follow-up in two HIV cohorts in Australia and Asia: implications for 'test and treat' prevention strategy.
P2860
Clonal resistance analyses of HIV type-1 after failure of therapy with didanosine, lamivudine and tenofovir
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clonal resistance analyses of ...... sine, lamivudine and tenofovir
@ast
Clonal resistance analyses of ...... sine, lamivudine and tenofovir
@en
type
label
Clonal resistance analyses of ...... sine, lamivudine and tenofovir
@ast
Clonal resistance analyses of ...... sine, lamivudine and tenofovir
@en
prefLabel
Clonal resistance analyses of ...... sine, lamivudine and tenofovir
@ast
Clonal resistance analyses of ...... sine, lamivudine and tenofovir
@en
P2093
P2860
P356
P1433
P1476
Clonal resistance analyses of ...... sine, lamivudine and tenofovir
@en
P2093
Christian Bixby
Dianna Koontz
Douglas Barnas
Holly Bazmi
John W Mellors
Joseph Jemsek
P2860
P304
P356
10.3851/IMP1539
P577
2010-01-01T00:00:00Z